Lv3
360 积分 2025-10-22 加入
Hepatectomy alters adjuvant anti–PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy
1天前
求助中
CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma
1天前
已完结
Checkpoint inhibitor hepatotoxicity: pathogenesis and management
8天前
已完结
Immune checkpoint inhibitor resistance in hepatocellular carcinoma
16天前
已完结
Yttrium-90 radioembolization is associated with a lower risk of liver transplant waitlist dropout than chemoembolization in hepatocellular carcinoma
25天前
已完结
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration
1个月前
已完结
Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study
1个月前
已完结
Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort study
1个月前
已完结
Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study
1个月前
已完结
The Future of Liver Transplantation
1个月前
已完结
皖公网安备34019202002308
